These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24345448)

  • 1. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
    van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
    Sagar V; Zheng W; Thompson PR; Cole PA
    Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
    Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
    Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
    Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
    Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone acetyl transferases as emerging drug targets.
    Dekker FJ; Haisma HJ
    Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New potent bisubstrate inhibitors of histone acetyltransferase p300: design, synthesis and biological evaluation.
    Kwie FH; Briet M; Soupaya D; Hoffmann P; Maturano M; Rodriguez F; Blonski C; Lherbet C; Baudoin-Dehoux C
    Chem Biol Drug Des; 2011 Jan; 77(1):86-92. PubMed ID: 21118378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs.
    Karukurichi KR; Cole PA
    Bioorg Chem; 2011 Feb; 39(1):42-7. PubMed ID: 21111442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
    Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
    Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.
    Mai A; Rotili D; Tarantino D; Nebbioso A; Castellano S; Sbardella G; Tini M; Altucci L
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1132-5. PubMed ID: 19144517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
    Bowers EM; Yan G; Mukherjee C; Orry A; Wang L; Holbert MA; Crump NT; Hazzalin CA; Liszczak G; Yuan H; Larocca C; Saldanha SA; Abagyan R; Sun Y; Meyers DJ; Marmorstein R; Mahadevan LC; Alani RM; Cole PA
    Chem Biol; 2010 May; 17(5):471-82. PubMed ID: 20534345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases.
    Sbardella G; Castellano S; Vicidomini C; Rotili D; Nebbioso A; Miceli M; Altucci L; Mai A
    Bioorg Med Chem Lett; 2008 May; 18(9):2788-92. PubMed ID: 18434144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
    Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
    Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of benzamides related to anacardic acid and their histone acetyltransferase (HAT) inhibitory activities.
    Souto JA; Conte M; Alvarez R; Nebbioso A; Carafa V; Altucci L; de Lera AR
    ChemMedChem; 2008 Sep; 3(9):1435-42. PubMed ID: 18537201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.
    Ghizzoni M; Wu J; Gao T; Haisma HJ; Dekker FJ; George Zheng Y
    Eur J Med Chem; 2012 Jan; 47(1):337-44. PubMed ID: 22100137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein modification by strain-promoted alkyne-azide cycloaddition.
    van Hest JC; van Delft FL
    Chembiochem; 2011 Jun; 12(9):1309-12. PubMed ID: 21557431
    [No Abstract]   [Full Text] [Related]  

  • 16. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.
    Liu X; Wang L; Zhao K; Thompson PR; Hwang Y; Marmorstein R; Cole PA
    Nature; 2008 Feb; 451(7180):846-50. PubMed ID: 18273021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isothiazolones; thiol-reactive inhibitors of cysteine protease cathepsin B and histone acetyltransferase PCAF.
    Wisastra R; Ghizzoni M; Maarsingh H; Minnaard AJ; Haisma HJ; Dekker FJ
    Org Biomol Chem; 2011 Mar; 9(6):1817-22. PubMed ID: 21267493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of novel inhibitors of histone acetyltransferases.
    Eliseeva ED; Valkov V; Jung M; Jung MO
    Mol Cancer Ther; 2007 Sep; 6(9):2391-8. PubMed ID: 17876038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase.
    Ghizzoni M; Haisma HJ; Dekker FJ
    Eur J Med Chem; 2009 Dec; 44(12):4855-61. PubMed ID: 19683843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current development of CBP/p300 inhibitors in the last decade.
    He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
    Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.